• Global expansion strategy: NephroPlus follows a three-pronged model targeting 40–50 new clinics in India and 10–15 in the Philippines annually, while opening a new country every one to two years across its roughly 520-clinic global network.
• Philippines network growth: Adding seven clinics in the first quarter expanded the company's Philippines footprint to 50 centers, making it the country's second-largest dialysis operator behind the market leader at 52 clinics.
• International unit economics: International operations contribute 40–42% of total revenue, delivering margin and ROCE profiles of around 20% by deploying its India cost structure to markets like the Philippines, where pricing is five times higher at $100.
• Geographic pipeline: Alongside existing operations in Nepal and Uzbekistan, the company plans to open a pilot clinic in Saudi Arabia within a month and pursue tenders across CIS and Middle Eastern markets.
• Philippines payer model: Dialysis services in the Philippines are predominantly funded via 100% reimbursements under the government's PhilHealth universal healthcare scheme, providing predictable revenue streams.